2021 Braude Foundation Award Recipients

Postdoctoral Trainees

Ewa Galaj  THERAPEUTIC POTENTIAL OF PIMSR1, A NOVEL CB1 NEUTRAL ANTAGONIST, FOR COCAINE USE DISORDER: EVIDENCE FROM PRECLINICAL RESEARCH
Francesca Palese TARGETING NAAA COUNTERS DOPAMINE NEURON LOSS AND SYMPTOM PROGRESSION IN A MOUSE MODEL OF PARKINSON’S DISEASE
Jacqueline-Marie Ferland ADOLESCENT THC HAS DOSE-DEPENDENT EFFECTS ON REWARD, STRESS REACTIVITY, AND DECISION MAKING IN ADULTHOOD VIA PERTURBATIONS IN ASTROCYTES
Kiesha Wilson TREATMENT OF SEB-INDUCED ARDS WITH CBD AMELIORATES FATAL INFLAMMATORY RESPONSE
Stephanie Lake  CANNABIS USE FOR ANXIETY DURING THE COVID-19 PANDEMIC IN THE UNITED STATES
   

Predoctoral Trainees

Alexis League INHIBITION OF MONOACYLGLYCEROL LIPASE ALTERS DENDRITIC BRANCHING COMPLEXITY AND REWARD-RELATED BEHAVIOR IN TAT TRANSGENIC MICE
Alexis Papariello CB1 ANTAGONISM INCREASES EXCITATORY SYNAPTOGENESIS IN A CORTICAL SPHEROID MODEL OF FETAL BRAIN DEVELOPMENT
Beth Wiese BRAIN PENETRANT, BUT NOT PERIPHERALLY RESTRICTED, SYNTHETIC CANNABINOID 1 RECEPTOR AGONISTS PROMOTE MORPHINE-MEDIATED RESPIRATORY DEPRESSION
Chante Muller UNIQUE ENTRY OF ANANDAMIDE AT TRPV1
Clare Diester EFFECTS OF ENDOCANNABINOID CATABOLIC ENZYME INHIBITORS AND ∆9-TETRAHYDROCANNABINOL ON ACUTE PAIN-DEPRESSED NESTING IN MICE
Clare Johnson GPR55 ANTAGONIST ML193 AND AGONIST O-1602 HAVE CELL AND TIME-DEPENDENT EFFECTS ON LIPID REGULATION
Erin Johnson PHYTOCANNABINOID CONCENTRATIONS IN HEMP DERIVED PRODUCTS: LC-MS/MS ASSAY VALIDATION AND QUANTIFICATION OUTCOMES
Lucy Sloan CANNABIDIOL INHIBITS ANGIOGENIC PROCESSES  IN RETINAL MICROVASCULAR ENDOTHELIAL CELLS
S. Olivia Vanegas NOVELTY-INDUCED HYPOPHAGIA AS A MEASURE OF SPONTANEOUS CANNABINOID WITHDRAWAL
Veronika Kondev UTILIZING A NOVEL ENDOCANNABINOID BIOSENSOR TO ELUCIDATE CIRCUIT-SPECIFIC ENDOCANNABINOID REGULATION OF VENTRAL HIPPOCAMPUS-BASOLATERAL AMYGDALA
Xintian Lyu DOSAGE AND FORMULATIONS RECEIVED BY PATIENTS WITHIN A US STATE CANNABIS PROGRAM